Sunday, October 4, 2026

USD/EUR Bearish Momentum: 0.794% Down In The Last 24 Hours

USD/EUR Bearish Momentum: 0.794% Down In The Last 24 Hours

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.7937% for the last session's close. At 19:08 EST on Wednesday, 1 March, USD/EUR (USDEUR) is $0.94.

USD/EUR (USDEUR) Range

Concerning USD/EUR's daily highs and lows, it's 0.213% down from its trailing 24 hours low of $0.94 and 0.804% down from its trailing 24 hours high of $0.95.

USD/EUR's yearly highs and lows, it's 4.831% up from its 52-week low and 10.571% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.26%, 0.23%, and 0.43%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.47% (last month), and 0.43% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy steadies above 136.00 as yields pause previous retreat, boj dovish stance appears safe. According to FXStreet on Tuesday, 28 February, "On the other hand, market sentiment improves on headlines suggesting the fact that the US offers an olive branch to Chinese companies despite its political differences with the dragon nation and hence challenges the USD/JPY bears due to the quote's risk-barometer status. ", "Despite reversing from a three-week-old ascending resistance line, around 136.90 by the press time, USD/JPY remains bullish unless breaking the 200-day Exponential Moving Average (EMA) support of 133.90."
  • Usd/jpy to move toward 125 at the end of 2023 – socgen. According to FXStreet on Tuesday, 28 February, "We expect the Japanese Yen to resume appreciating and the USD/JPY pair to move toward 125 at the end of 2023."
  • Usd/jpy clings to gains near YTD peak, seems poised to appreciate further. According to FXStreet on Tuesday, 28 February, "A fresh leg up in the US Treasury bond yields, bolstered by hawkish Fed expectations, helps revive the US Dollar demand, which, in turn, acts as a tailwind for the USD/JPY pair. ", "Nevertheless, the fundamental backdrop suggests that the path of least resistance for the USD/JPY pair is to the upside. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Citigroup Inc.
Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com